BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Prognosis
178 results:

  • 1. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer.
    Zou H; Luo J; Guo Y; Deng L; Zeng L; Pan Y; Li P
    Drug Resist Updat; 2024 Mar; 73():101051. PubMed ID: 38219531
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting src kinase autophosphorylation.
    Zhong W; Jian Y; Zhang C; Li Y; Yuan Z; Xiong Z; Huang W; Ouyang Y; Chen X; Song L; Liu P; Wang X
    Cancer Lett; 2024 Feb; 582():216516. PubMed ID: 38052369
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
    Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development.
    Dai H; Xu W; Wang L; Li X; Sheng X; Zhu L; Li Y; Dong X; Zhou W; Han C; Mao Y; Yao L
    Breast Cancer Res; 2023 Jul; 25(1):90. PubMed ID: 37507768
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Casein kinase 1 controls the shuttling of epidermal growth factor receptor and estrogen receptor in endometrial carcinoma induced by breast cancer hormonal therapy: Relevance of GPER1/src.
    Hoang LN; Lee SJ
    Cell Signal; 2023 Aug; 108():110733. PubMed ID: 37257767
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CircKIF4A combines EIF4A3 to stabilize SDC1 expression to activate c-src/FAK and promotes TNBC progression.
    Luo P; Gong Y; Weng J; Wen F; Luo J; Hu C; Xiao J; Shu J
    Cell Signal; 2023 Aug; 108():110690. PubMed ID: 37121557
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma.
    Zhu J; Zhang J; Hu P; Fan M; Song D; Yin H; Yan P; Xian S; Li Z; Guo J; Long C; Xu R; Huang R; Meng T; Zhang J; Huang Z
    Biochem Genet; 2023 Dec; 61(6):2242-2259. PubMed ID: 37010714
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Chemokine (C-C motif) Ligand 2 Is Regulated Through the EGFR/src Pathway in HER2-positive breast cancer Cells.
    You D; Kim H; Jeong Y; Yoon SY; Lo E; Lee JE; Kim S
    Anticancer Res; 2023 Mar; 43(3):1079-1089. PubMed ID: 36854521
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A reversible src-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF
    Ruiz-Saenz A; Atreya CE; Wang C; Pan B; Dreyer CA; Brunen D; Prahallad A; Muñoz DP; Ramms DJ; Burghi V; Spassov DS; Fewings E; Hwang YC; Cowdrey C; Moelders C; Schwarzer C; Wolf DM; Hann B; VandenBerg SR; Shokat K; Moasser MM; Bernards R; Gutkind JS; van 't Veer LJ; Coppé JP
    Nat Cancer; 2023 Feb; 4(2):240-256. PubMed ID: 36759733
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
    Su L; Chen Y; Huang C; Wu S; Wang X; Zhao X; Xu Q; Sun R; Kong X; Jiang X; Qiu X; Huang X; Wang M; Wong PP
    Sci Transl Med; 2023 Jan; 15(678):eabl7895. PubMed ID: 36630483
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation.
    Li J; Xia Q; Di C; Li C; Si H; Zhou B; Yu S; Li Y; Huang J; Lu Y; Huang M; Liang H; Liu X; Zhao Q
    Adv Sci (Weinh); 2023 Mar; 10(7):e2202956. PubMed ID: 36581470
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. COL8A1 enhances the invasion/metastasis in MDA-MB-231 cells via the induction of IL1B and MMP1 expression.
    Sagara A; Miura S; Kobinata A; Naganawa R; Yaginuma S; Saito S; Saito R; Kominato H; Yumoto T; Sato F
    Biochem Biophys Res Commun; 2023 Jan; 642():145-153. PubMed ID: 36577251
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. BAIAP2L1 accelerates breast cancer progression and chemoresistance by activating AKT signaling through binding with ribosomal protein L3.
    Deng N; Zhang X; Zhang Y
    Cancer Sci; 2023 Mar; 114(3):764-780. PubMed ID: 36308067
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. FOXD1-dependent RalA-ANXA2-src complex promotes CTC formation in breast cancer.
    Long Y; Chong T; Lyu X; Chen L; Luo X; Faleti OD; Deng S; Wang F; He M; Qian Z; Zhao H; Zhou W; Guo X; Chen C; Li X
    J Exp Clin Cancer Res; 2022 Oct; 41(1):301. PubMed ID: 36229838
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. STAT3 and PD-L1 are negatively correlated with ATM and have impact on the prognosis of triple-negative breast cancer patients with low ATM expression.
    Song YM; Qian XL; Xia XQ; Li YQ; Sun YY; Jia YM; Wang J; Xue HQ; Gao GS; Wang XZ; Zhang XM; Guo XJ
    Breast Cancer Res Treat; 2022 Nov; 196(1):45-56. PubMed ID: 36056297
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Estrogen receptor variant ER-α36 facilitates estrogen signaling via EGFR in glioblastoma.
    Qu C; Wang C; Li H; Li Y; Han C; Tao X; Guan X; Zhang Y; Chen M; Liu J; Zou W
    Cell Biol Int; 2022 Nov; 46(11):1759-1774. PubMed ID: 35930599
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3.
    Liu C; Wang J; Zheng Y; Zhu Y; Zhou Z; Liu Z; Lin C; Wan Y; Wen Y; Liu C; Yuan M; Zeng YA; Yan Z; Ge G; Chen J
    Oncogene; 2022 Aug; 41(34):4091-4103. PubMed ID: 35854065
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. DDR1 promotes migration and invasion of breast cancer by modulating the src-FAK signaling.
    Han Q; Xiao F; Ma L; Zhou J; Wang L; Cheng H; Zhu J; Yao F; Lyu J; Du L
    Neoplasma; 2022 Sep; 69(5):1154-1164. PubMed ID: 35818965
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/src signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer.
    Liu J; Yang CQ; Chen Q; Yu TY; Zhang SL; Guo WH; Luo LH; Zhao G; Yin DC; Zhang CY
    Biomater Sci; 2022 Aug; 10(16):4596-4611. PubMed ID: 35792605
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.